EP4142770
SEMAGLUTIDE FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
26.4.2021EP published:
11.3.2026EP application number:
21721092.1
EPO information:
European Patent Register
Max expiry date:
25.4.2041Expiry date:
10.7.2026
Title in English:
SEMAGLUTIDE FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITISLanguage of the patent:
English
Timeline
Today
26.4.2021EP application
11.3.2026EP Publication
10.7.2026Expires
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880 Bagsværd, DK
Inventor
Name:
LINDER, MartinAddress:
2880 Bagsværd, DK
Name:
PALLE, Mads, SundbyAddress:
2880 Bagsværd, DK
Name:
DAMGAARD, Lars, HolmAddress:
2880 Bagsværd, DK
Name:
HANSEN, MortenAddress:
2880 Bagsværd, DK
Name:
TORSTENSON, Carl RichardAddress:
2880 Bagsværd, DK
Priority
Number:
20171536Date:
27.4.2020Country:
EP
Number:
20173341Date:
6.5.2020Country:
EP
Classification
Categories:
A61K 38/26, A61P 1/16